Methylated p16INK4A was significantly associated with tumor size, in which it was higher in pT2-4 patients than in pT1 patients, suggesting that p16INK4A promoter methylation may play a key role in the pathogenesis of T2-4, whereas methylated p14ARF was not significantly correlated with tumor size. This evidence concerns the gene CDKN2A and neoplasm.